@article{4b93382e552f4d53b456eb578a9e9a3c,
title = "COVID-19 and the Urgent Need for New Therapies for Obesity",
keywords = "COVID-19, new therapies, obesity, obesity and COVID-19 pandemics, population health",
author = "Greenway, {Frank L.} and Michelle Look and Angela Golden and Irfan Asif and Joe Nadglowski and Ted Kyle and Leider, {Harry L.}",
note = "Funding Information: Dr. Greenway receives consulting fees from Jazz Pharmaceutical, Basic Research, Dr. Reddy{\textquoteright}s Lab, General Nutrition Corporation, and Novmeta Pharma; is on the scientific advisory board of Jenny Craig; has received grants from Pfizer, Novartis, Epitomee, Novo Nordisk, and Gelesis; has stock/stock options in Plensat, Slim Health Nutrition, KE Diets, Nutracado, and UR Labs; and has lab contracts with Novmeta Pharma and Melior Discoveries. Dr. Look is on the advisory board of Gelesis (honoraria), and Boehringer Ingelheim (honoraria); she declares no conflicts of interest. Dr. Golden is in the speakers bureau for and is a consultant to NovoNordisk, and is a consultant to Unjury. Dr. Asif declares that he has no conflicts of interest. Mr. Nadglowski declares that he has no conflicts of interest or disclosures other than employment by the Obesity Action Coalition. Mr. Kyle receives consulting fees from Tivity Health, Novo Nordisk, and Gelesis. Dr. Leider is a full-time employee of and holds stock options in Gelesis.",
year = "2021",
month = oct,
doi = "10.1089/pop.2020.0307",
language = "English (US)",
volume = "24",
pages = "531--534",
journal = "Population Health Management",
issn = "1942-7891",
publisher = "Mary Ann Liebert Inc.",
number = "5",
}